EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudie

Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer

Kentaro Sato, Rei Suzuki, Naoki Konno, Hiroki Irie, K O Watanabe, Hiromichi Imaizumi, Yuichi Waragai, Mitsuru Sugimoto, Hiroyuki Asama, Hiroshi Shimizu, Rei Ohira, Hiromasa Ohira

Anticancer Research · 2025

DOI: 10.21873/anticanres.17798 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Anticancer Research, 2025. Verfasst von Kentaro Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nomograms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNomogramsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesGemcitabineLeucovorinPaclitaxelDeoxycytidineAdultAged, 80 and overC-Reactive ProteinOxaliplatinIrinotecanFluorouracil

Stichwörter der Autor:innen

Pancreatic cancerpredictionsecond-line chemotherapy

Substanzen

GemcitabineLeucovorinPaclitaxelDeoxycytidineC-Reactive ProteinOxaliplatinfolfirinoxIrinotecanFluorouracil

Autor:innen und Institutionen

  • Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan; subaru@fmu.ac.jp.
  • Department of Gastroenterology, Fukushima Red Cross Hospital, Fukushima, Japan.
  • Department of Gastroenterology, Ohara General Hospital, Fukushima, Japan.
  • Department of Gastroenterology, Iwase General Hospital, Fukushima, Japan.
  • Department of Gastroenterology, Soma General Hospital, Fukushima, Japan.

Zitieren

APA

Sato, K., Suzuki, R., Konno, N., Irie, H., Watanabe, K. O., Imaizumi, H., Waragai, Y., Sugimoto, M., Asama, H., Shimizu, H., Ohira, R., & Ohira, H. (2025). Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17798

Vancouver

Sato K, Suzuki R, Konno N, Irie H, Watanabe KO, Imaizumi H, et al. Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17798

BibTeX
@article{Sato2025,
  author = {Sato, Kentaro and Suzuki, Rei and Konno, Naoki and Irie, Hiroki and Watanabe, K O and Imaizumi, Hiromichi and Waragai, Yuichi and Sugimoto, Mitsuru and Asama, Hiroyuki and Shimizu, Hiroshi and Ohira, Rei and Ohira, Hiromasa},
  title = {Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17798}
}
Kostenlos starten →